- The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil2023 | Publication without faculty affiliation
- Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE2020 | First Faculty of Medicine
- Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension2021 | First Faculty of Medicine